GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ArcticZymes Technologies ASA (LTS:0DRV) » Definitions » ROE % Adjusted to Book Value

ArcticZymes Technologies ASA (LTS:0DRV) ROE % Adjusted to Book Value : -0.69% (As of Sep. 2024)


View and export this data going back to 2007. Start your Free Trial

What is ArcticZymes Technologies ASA ROE % Adjusted to Book Value?

ArcticZymes Technologies ASA's ROE % for the quarter that ended in Sep. 2024 was -1.96%. ArcticZymes Technologies ASA's PB Ratio for the quarter that ended in Sep. 2024 was 2.84. ArcticZymes Technologies ASA's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2024 was -0.69%.


ArcticZymes Technologies ASA ROE % Adjusted to Book Value Historical Data

The historical data trend for ArcticZymes Technologies ASA's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ArcticZymes Technologies ASA ROE % Adjusted to Book Value Chart

ArcticZymes Technologies ASA Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
ROE % Adjusted to Book Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.47 4.50 1.09 0.98 0.94

ArcticZymes Technologies ASA Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.72 0.06 0.86 0.82 -0.69

Competitive Comparison of ArcticZymes Technologies ASA's ROE % Adjusted to Book Value

For the Biotechnology subindustry, ArcticZymes Technologies ASA's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ArcticZymes Technologies ASA's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, ArcticZymes Technologies ASA's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where ArcticZymes Technologies ASA's ROE % Adjusted to Book Value falls into.



ArcticZymes Technologies ASA ROE % Adjusted to Book Value Calculation

ArcticZymes Technologies ASA's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=6.54% / 6.93
=0.94%

ArcticZymes Technologies ASA's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-1.96% / 2.84
=-0.69%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


ArcticZymes Technologies ASA ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of ArcticZymes Technologies ASA's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.


ArcticZymes Technologies ASA Business Description

Traded in Other Exchanges
Address
Sykehusveien 23, Tromso, NOR, 9294
ArcticZymes Technologies ASA is a biotechnology company. The company is engaged in developing, producing, and marketing immune-modulating beta-glucans and novel recombinant enzymes. The company's products include Woulgan wound gel, Feed Ingredient (M-Glucan), Nutraceuticals (M-Gard), Recombinant enzymes, and others. The company reports in two operating segments, Enzymes and Corporate. Geographically, it derives a majority of revenue from the USA followed by Lithuania, Germany, Italy, France, and other countries.

ArcticZymes Technologies ASA Headlines

No Headlines